Semaglutide Causing Diarrhoea: What the Evidence Shows and What to Do

How common is diarrhoea in the semaglutide trials, and why does it happen?

The STEP 1 trial, published in the New England Journal of Medicine, remains the landmark study for semaglutide 2.4 mg in weight management. Of the 1,306 adults assigned to semaglutide, around 30% reported diarrhoea during the 68-week study, making it the second most common gastrointestinal side effect after nausea. The placebo rate of roughly 16% matters here: it shows the drug is contributing, but also that GI symptoms occur in a meaningful minority of people regardless.

Why? Semaglutide acts on GLP-1 receptors throughout the gut as well as the brain. Slowing gastric emptying is part of how it reduces appetite, but that shift in gut motility can work unevenly, for some people it produces constipation, for others looser stools, and occasionally both at different points in treatment. The effect is more pronounced in the early weeks after starting or after a dose increase, because the gut is adapting to a new hormonal signal. That is why loose stools linked to semaglutide often ease once a dose has settled, rather than persisting throughout.

Wegovy causing diarrhoea is not a sign that something has gone wrong, it is a documented, predictable pharmacological effect. That said, predictable does not mean trivial, and the steps below matter.

Managing diarrhoea on semaglutide day to day

Small, practical adjustments make a real difference for most people. Eating slowly, avoiding high-fat or very spicy meals, and keeping portions modest reduces the GI load on a gut already slowed by the medicine. Hydration is the single most important thing: loose stools deplete fluids and electrolytes faster than people expect, particularly if appetite is already suppressed and drinking feels like an effort.

If you keep your pen in the fridge door (which is fine for short-term storage) keeping a large glass of water alongside it as a morning prompt is a habit that several of our patients find genuinely useful. Simple, but worth building in from day one.

Spacing meals further apart and prioritising plain, easily digestible foods during the first few weeks of a new dose is the approach most clinicians suggest. Practical steps for managing diarrhoea on semaglutide are covered in more detail in our dedicated guide. Our prescribers also discuss individual dietary adjustments as part of aftercare, that kind of support is available seven days a week through our contact team.

Over-the-counter remedies such as loperamide are sometimes used short-term; whether that is appropriate for you is a conversation to have with your prescriber or pharmacist, not something to start unilaterally on a prescription medicine.

When to get medical help

Most diarrhoea on semaglutide is mild and self-limiting. There are situations, however, where you should seek prompt medical attention rather than waiting it out.

Contact a doctor or NHS 111 if you develop signs of dehydration (dizziness on standing, very dark urine, dry mouth, or feeling faint) because dehydration on a GLP-1 medicine can put strain on the kidneys. Severe or bloody diarrhoea, or diarrhoea that has persisted for more than a few days without any improvement, also needs clinical assessment.

The symptom combination that requires urgent attention is severe, persistent abdominal pain that radiates to the back, with or without vomiting. This pattern can indicate acute pancreatitis, which the MHRA flagged in a January 2026 Drug Safety Update as an infrequent but serious known risk with GLP-1 medicines. It is uncommon; it is worth knowing about.

If you experience any side effect you're uncertain about, you can report it directly to the MHRA through the Yellow Card scheme. Reports from patients help regulators monitor how medicines perform in the real world, and the scheme is free and straightforward to use. You can also read a full overview of Wegovy's side effect profile for context on what the broader picture looks like.

Diarrhoea versus other GI side effects: keeping the picture in proportion

Semaglutide's GI side effects as a group (nausea, diarrhoea, constipation, vomiting, reflux) are well documented and are the main reason the licensed titration schedule starts low and moves slowly. The NHS's patient information for semaglutide confirms this pattern and notes that most GI effects are most intense around dose increases. You can read the NHS semaglutide medicines page for the full list of common and uncommon effects.

For people who find fatigue or nausea more troublesome than diarrhoea, the picture can look quite different week to week. It is worth keeping a simple note of which symptoms arise after a dose increase and how long they last, that information is genuinely useful to a prescriber reviewing whether the current dose is right for you.

Diarrhoea alone very rarely requires stopping treatment. But the decision about whether to slow titration, hold a dose, or continue as planned belongs with your prescriber, not a best guess made alone. If you haven't yet started treatment and want to understand the full side-effect landscape before committing, our prescribers cover exactly this during the consultation, check your eligibility to begin that conversation.